Literature DB >> 301194

Masking of receptors for sheep erythrocytes on human T-lymphocytes by sera from breast cancer patients.

R H Whitehead, G P Roberts, J Thatcher, C Teasdale, L E Hughes.   

Abstract

Sera from 140 breast cancer patients and 38 controls were tested for their ability to inhibit sheep erythrocyte (E) rosette formation by normal, allogeneic lymphocytes. Inhibition of rosette formation by greater than 20% was found with 65% of stage I sera, 91% of stage II sera, 56% of stage III sera, and all stage IV sera. In contrast, only 13% of control sera was inhibitory. The inhibitory factor was found to bind to only a proportion of T-lymphocytes and could be removed from these lymphocytes by mild proteolytic digestion or extended washing. Examination of the properties of the inhibitory factor indicated that it differed from other substances that reportedly inhibited E-rosette formation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301194     DOI: 10.1093/jnci/58.6.1573

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  3 in total

1.  Immunosuppression by breast cancer associated p43-effect of immunomodulators.

Authors:  H R Rosen; C Ausch; G Reiner; M Reinerova; J Svec; H Tüchler; R Schiessel; C Moroz
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Significance of tumour mass on T-lymphocyte levels in patients with gastrointestinal cancer.

Authors:  H S Shukla; R H Whitehead; L E Hughes
Journal:  Gut       Date:  1979-08       Impact factor: 23.059

3.  Importance of methodology in demonstrating depression of T-lymphocyte levels.

Authors:  R H Whitehead; G P Roberts; L E Hughes; J Thatcher
Journal:  Br J Cancer       Date:  1978-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.